Paclitaxel

ATP binding cassette subfamily B member 1 ; Homo sapiens







527 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
501 9780138 Therapeutic approach to drug resistant tumors. 1998 Oct 1
502 9803961 Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. 1998 Nov 1 1
503 9865905 Relationship between paclitaxel activity and pathobiology of human solid tumors. 1998 Dec 2
504 9009089 Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. 1997 Feb 4
505 9070502 Differential activity of Cremophor EL and paclitaxel in patients' tumor cells and human carcinoma cell lines in vitro. 1997 Mar 15 1
506 9105396 Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. 1997 Feb 21 3
507 9219509 Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration. 1997 6
508 9272128 Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. 1997 1
509 9380024 The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. 1997 Oct 1
510 9815684 Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model. 1997 Feb 1
511 8573197 Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system. 1996 Feb 9 3
512 8616855 Pharmacodynamics of taxol in human head and neck tumors. 1996 May 1 5
513 8831715 Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. 1996 Oct 11 1
514 8877707 Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection. 1996 Aug 2
515 9042212 Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. 1996 Nov-Dec 1
516 9816243 Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells. 1996 May 1
517 21544450 P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A. 1996 May 1
518 7552988 Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. 1995 Jun 1
519 7552989 Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. 1995 Jun 1
520 7622101 Cell biological markers of drug resistance in ovarian carcinoma. 1995 Aug 1
521 7645972 Addition of hTNF alpha potentiates cytotoxicity of taxol in human ovarian cancer lines. 1995 May-Jun 1
522 7669666 Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection. 1995 Aug 3
523 7670142 Development of drug resistance is reduced with idarubicin relative to other anthracyclines. 1995 Jun 1
524 7749130 Current status of paclitaxel in the treatment of breast cancer. 1995 6
525 7912530 Taxol: mechanisms of action and resistance. 1993 2
526 8104544 A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. 1993 Aug 1
527 8105099 Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. 1993 Oct 20 3